“Comparison of Drug Regimens (Sofosbuvir and velpatasvir versus Sofosbuvir and Daclatasvir) in Treatment of Chronic Hepatitis C Virus Patients in Terms of Efficacy and Safety ”, mfm, vol. 34, no. 10, Nov. 2023, doi: 10.60110/medforum.341023.